Acil Servise Düşük Tehdidi Nedeniyle Başvuran Hastalarda Sistemik Inflamatuar Belirteçlerin Gebelik Sonuçlarını Öngörmede Etkisi

Amaç: Erken gebelikte vajinal kanama acil servise en sık başvuru sebepleri arasındadır. Bu olgulardainflamasyonun önemli bir rol oynadığı ve ilerleyen dönemde oluşabilecek düşüklerin habercisiolabileceği düşünülmektedir. Çalışmanın amacı, abortus imminens (AI) tanısı ile acil servise başvuruphospitalize edilen hastalarda nötrofil‐lenfosit oranı (NLO) ve platelet‐lenfosit oranlarının (PLO)incelenmesi ve bu belirteçlerin gebelik sonuçlarını öngörmedeki etkinliklerinin değerlendirilmesidir.Materyal ve Metot: Üniversite hastanesi acil servisine, gebeliğinin ilk 14 haftası içerisinde vajinalkanama şikâyeti ile başvurup AI tanısı alan toplam 121 hasta çalışmaya dahil edilmiştir. Bu hastalar;gebeliklerini abortus nedeniyle kaybedenler (n=73; %60,33) ve 24. hafta sonrasında gebeliği devamedenler (n=48; %39,66) olarak iki gruba ayrılmış olup, demografik veriler, inflamatuar belirteçler vediğer hematolojik parametreler açısından karşılaştırılmıştır.Bulgular: Gruplar arasındaki demografik veriler benzer olarak saptanmıştır. Abortus grubunda NLOanlamlı şekilde yüksek bulunmuştur (3,92±2,01 ve 2,94±1,20; p

The Effect of Systemic Inflammation Markers on Predicting Pregnancy Results in Patients Admitted to Emergency Department with Threatened Miscarriage

Objectives: Vaginal bleeding in early pregnancy is one of the most common causes of emergency department (ED) admissions. It is thought that inflammation plays an important role in these cases and may be a predictor of miscarriages. The aim of this study was to evaluate the efficacy of neutrophil‐ lymphocyte ratio (NLR) and platelet‐lymphocyte ratio (PLR) in predicting pregnancy outcomes in patients admitted to ED with abortus imminens (AI). Materials and Methods: A total of 121 patients admitted to the ED of a university hospital with the complaint of vaginal bleeding within the first 14 weeks of gestation with AI diagnosis were included in the study. These patients were divided into two groups; pregnant women who lost their pregnancies due to abortion (n = 73, 60,33%) and those who continued pregnancy after 24 weeks (n = 48, 39,66%). Demographic data, inflammatory markers and other hematological parameters were compared between the groups. Results: Demographic data were comparable between the groups. NLR was significantly higher in the abortion group (3,92 ± 2,01 vs. 2,94 ± 1,20, p

PDF

___

1. Nanda K, Lopez LM, Grimes DA, Peloggia A, Nanda G. Expectant care versus surgical treatment for miscarriage. Cochrane Database Syst Rev 2012; :CD003518.
2. Tongsong T, Srisomboon J, Wanapirak C, Sirichotiyakul S, Pongsatha S, Polsrisuthikul T. Pregnancy outcome of threatened abortion with demonstrable fetal cardiac activity: a cohort study. J Obstet Gynaecol (Tokyo 1995) 1995;21:331‐5.
3. Tannirandorn Y, Sangsawang S, Manotaya S, Uerpairojkit B, Samritpradit P, Charoenvidhya D. Fetal loss in threatened abortion after embryonic/fetal heart activity. Int J Gynaecol Obstet 2003; 81:263‐6.
4. Kaplanoglu M, Yuce T, Bulbul M. Decreased mean platelet volume is associated with the developing stage of fetoplacental unit in spontaneous abortion. Int J Clin Exp Med. 2015;8(7):11301‐6.
5. Goldenberg R, Culhane J, Iams J, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371:75‐84.
6. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 2011;17:47‐58.
7. Emektar E, Çorbacıoğlu ŞK, Dağar S, et al. Prognostic value of the neutrophil–lymphocyte and platelet–lymphocyte ratios in predicting one‐year mortality in patients with hip fractures and aged over 60 years. Eurasian J Emerg Med 2017; 16:165‐70.
8. Gökhan Ş, Yıldırım C, Günaydın GP, et al. Thiol/disulphide homeostasis neutrophil lymphocyte and platelet lymphocyte ratio in emergency department patients with renal colic. Ankara Med J, 2018;(4):657‐63.
9. Posul E, Yilmaz B, Aktas G, Kurt M. Does neutrophil‐to‐lymphocyte ratio predict active ulcerative colitis? Wiener Klinische Wochenschrift 2015; 127:262‐5.
10. Nording HM, Seizer P, Langer HF. Platelets in inflammation and atherogenesis. Front Immunol 2015; 6:98.
11. Balta S, Ozturk C. The platelet‐lymphocyte ratio: a simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets 2015; 26:680‐1.
12. Nora I, Shridhar R, Huston J, Meredith K. The accuracy of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as a marker for gastrointestinal malignancies. J Gastrointest Oncol. 2018; 9(5):972‐8.
13. Bas FY, Tola EN, Sak S, Cankaya BA. The role of complete blood inflammation markers in the prediction of spontaneous abortion. Pak J Med Sci. 2018;34(6):1381‐5.
14. Araújo FDDR, Silva RMFDL, Oliveira CAL, Meira ZMA. Neutrophil‐to‐lymphocyte ratio used as prognostic factor marker for dilated cardiomyopathy in childhood and adolescence. Ann Pediatr Cardiol. 2019;12(1):18‐24.
15. İpek E, Yıldırım E, Cengiz M, et al. Neutrophil to lymphocyte and platelet to lymphocyte ratio and their relationship with canadian cardiovascular society angina classification in patients with chest pain. Ankara Med J, 2016;16(1):51‐60
16. Basama FM, Crosfill F. The outcome of pregnancies in 182 women with threatened miscarriage. Arch Gynecol Obstet 2004;270:86‐90.
17. Hill LM, Guzick D, Fries J, Hixson J. Fetal loss rate after ultrasonically documented cardiac activity between 6 and 14 weeks, menstrual age. J Clin Ultrasound 1991;19:221‐3.
18. Desale M, Thinkhamrop J, Lumbiganon P, Qazi S, Anderson J. Ending preventable maternal and newborn deaths due to infection. Best Pract Res Clin Obstet Gynaecol. 2016;36:116‐30.
19. Chaouat G, Dubanchet S, Ledee N. Cytokines: important for implantation? J Asist Reprod Genet 2007;24:491‐505.
20. Yu XW, Yan CF, Jin H, Li X. Tumor necrosis factor receptor 1 expression and early spontaneous abortion. Int J Gynaecol Obstet 2005; 88:44‐8.
21. Cakiroglu Y, Vural F, Vural B. The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes. J Endocrinal Invest. 2016; 39:899‐907.